We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Tarceva, Capecitabine and Oxaliplatin for Metastatic Colorectal Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00123851
Recruitment Status : Completed
First Posted : July 26, 2005
Last Update Posted : April 28, 2009
OSI Pharmaceuticals
Hoffmann-La Roche
Genentech, Inc.
Massachusetts General Hospital
Beth Israel Deaconess Medical Center
Information provided by:
Dana-Farber Cancer Institute